Influenza virus vaccine (Seqirus Pty)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInfluenza virus vaccine (Seqirus Pty)
Drug Alias NameAfluria
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Global Approved IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2007/09/28
Country/TerritoryUnited StatesAustralia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSeqirus
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSeqirusNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A